25 May 2013
Keywords: tap, co-promote, novartis, famvir, usa, pharmaceutical, products
Article | 09 October 2006
The USA's TAP Pharmaceutical Products has entered into an agreement to co-promote Swiss drug major Novartis' Famvir (famciclovir), an oral
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 October 2006
2 October 2006
24 May 2013
© 2013 thepharmaletter.com